BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12501692)

  • 1. [Molecular mechanism of the expression and modulation of CYP3A gene].
    Wang JS; Zhou HH
    Sheng Li Ke Xue Jin Zhan; 1998 Apr; 29(2):173-6. PubMed ID: 12501692
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues.
    Matheny CJ; Ali RY; Yang X; Pollack GM
    Drug Metab Dispos; 2004 Sep; 32(9):1008-14. PubMed ID: 15319343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of disease on expression and regulation of CYPs.
    Farrell G
    Mol Aspects Med; 1999; 20(1-2):55-70, 137. PubMed ID: 10575652
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of PXR, CYP3A and MDR1 genes in liver of zebrafish.
    Bresolin T; de Freitas Rebelo M; Celso Dias Bainy A
    Comp Biochem Physiol C Toxicol Pharmacol; 2005; 140(3-4):403-7. PubMed ID: 15914091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes.
    Schuetz EG; Umbenhauer DR; Yasuda K; Brimer C; Nguyen L; Relling MV; Schuetz JD; Schinkel AH
    Mol Pharmacol; 2000 Jan; 57(1):188-97. PubMed ID: 10617694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP3A genetics in drug metabolism.
    Eichelbaum M; Burk O
    Nat Med; 2001 Mar; 7(3):285-7. PubMed ID: 11231620
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of MDR1 and CYP3A expression by dexamethasone: evidence for an inverse regulation in adrenals.
    Sérée E; Villard PH; Hevér A; Guigal N; Puyoou F; Charvet B; Point-Scomma H; Lechevalier E; Lacarelle B; Barra Y
    Biochem Biophys Res Commun; 1998 Nov; 252(2):392-5. PubMed ID: 9826540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11.
    Anakk S; Kalsotra A; Kikuta Y; Huang W; Zhang J; Staudinger JL; Moore DD; Strobel HW
    Pharmacogenomics J; 2004; 4(2):91-101. PubMed ID: 14770174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP3A in horse intestines.
    Tydén E; Olsén L; Tallkvist J; Larsson P; Tjälve H
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):112-9. PubMed ID: 15541751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics. SNP-ing drugs to size.
    Gura T
    Science; 2001 Jul; 293(5530):595. PubMed ID: 11474082
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization.
    Chiou WL; Jeong HY; Wu TC; Ma C
    Clin Pharmacol Ther; 2001 Oct; 70(4):305-10. PubMed ID: 11673745
    [No Abstract]   [Full Text] [Related]  

  • 12. Risperidone-carbamazepine interactions: is cytochrome P450 3A involved?
    Lane HY; Chang WH
    J Clin Psychiatry; 1998 Aug; 59(8):430-1. PubMed ID: 9721825
    [No Abstract]   [Full Text] [Related]  

  • 13. Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C.
    Ding X; Staudinger JL
    Biochem Pharmacol; 2005 Mar; 69(5):867-73. PubMed ID: 15710363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats.
    Xu Y; Iwanaga K; Zhou C; Cheesman MJ; Farin F; Thummel KE
    Biochem Pharmacol; 2006 Jul; 72(3):385-92. PubMed ID: 16769037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochromes in psychopharmacology.
    von Moltke LL; Greenblatt DJ; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 1994 Feb; 14(1):1-4. PubMed ID: 8150999
    [No Abstract]   [Full Text] [Related]  

  • 16. Kupffer cells and reactive oxygen species partially mediate lipopolysaccharide-induced downregulation of nuclear receptor pregnane x receptor and its target gene CYP3a in mouse liver.
    Xu DX; Wei W; Sun MF; Wu CY; Wang JP; Wei LZ; Zhou CF
    Free Radic Biol Med; 2004 Jul; 37(1):10-22. PubMed ID: 15183191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP3A and drug interactions.
    Med Lett Drugs Ther; 2005 Jul; 47(1212):54-5. PubMed ID: 15988399
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipopolysaccharide and cecal ligation/puncture differentially affect the subcellular distribution of the pregnane X receptor but consistently cause suppression of its target genes CYP3A.
    Sachdeva K; Yan B; Chichester CO
    Shock; 2003 May; 19(5):469-74. PubMed ID: 12744492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral erythromycin and the risk of sudden death.
    Amory JK; Amory DW
    N Engl J Med; 2005 Jan; 352(3):301-4; author reply 301-4. PubMed ID: 15669119
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of transcription factor profile and chromatin conformation on human hepatocyte CYP3A gene expression.
    Phillips A; Hood SR; Gibson GG; Plant NJ
    Drug Metab Dispos; 2005 Feb; 33(2):233-42. PubMed ID: 15523048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.